第一个mRNA儿童病例COVID-19疫苗相关的新发症系统性肌痛危机
Serkan Kirik1, Mehmet Agar2, Hadice Gurkan Akyol3
1Department of Pediatric Neurology, Elazig Fethi Sekin City Hospital, Elazig, Türkiye.
Sisli Etfal Hastanesi tip bulteni
|February 17, 2026
概括
一个儿科病例的骨髓质疏松症 (MG) 在mRNACOVID-19疫苗后出现了严重的症状. 胸膜切除术显著改善了她的病情,突出了潜在的疫苗相关并发症.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性神经肌肉疾病.
- 胸腺在MG的发病过程中起着至关重要的作用,因此胸腺切除术成为一种潜在的治疗方法.
- 在COVID-19疫苗接种后报告了自身免疫并发症,包括MG恶化.
研究的目的:
- 报告该国BNT162b2 mRNA COVID-19疫苗接种后发生的第一个儿科骨髓灰质炎和胸腺瘤病例.
- 要突出mRNA疫苗和新发性MG与严重呈现之间的潜在关联.
- 强调甲状腺切除术在管理疫苗相关的MG中的作用.
主要方法:
- 一个以前健康的儿科患者的病例报告.
- 临床评估MG症状,包括普遍的虚弱和呼吸困难.
- 针对MG和胸腺瘤的诊断工作.
- 通过视频辅助胸腔镜手术 (VATS) 进行标准的MG治疗和随后的胸切除术的干预.
主要成果:
- 患者在接种BNT162b2疫苗后出现了严重的,危及生命的泛性肌痛性肌痛症.
- 最初的MG治疗没有显著的临床改善.
- 通过VATS进行胸膜切除术,使患者的临床状况大大改善.
- 在随访期间诊断出严重肌痛和胸腺瘤.
结论:
- 这一案例表明,mRNA COVID-19 疫苗接种与儿科患者严重肌痛性骨髓灰质炎的出现之间存在潜在联系.
- 胸膜切除术可以作为与疫苗相关的严重骨髓灰质炎的有效治疗方法.
- 这份报告是关于mRNA疫苗接种后潜在的自身免疫并发症的警告.
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
2.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.7K
01:20Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
01:30Acute Pharyngitis
4.6K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.6K
01:21Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
01:29Acute Respiratory Failure-V
525
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
525
01:21Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K